Latest filings (excl ownership)
10-Q
2024 Q1
Quarterly report
2 May 24
8-K
Arteris Announces Financial Results for the First Quarter 2024 and Second Quarter and Full Year 2024 Guidance
2 May 24
ARS
2023 FY
Annual report to shareholders
23 Apr 24
DEFA14A
Additional proxy soliciting materials
23 Apr 24
DEF 14A
Definitive proxy
23 Apr 24
S-8
Registration of securities for employees
20 Feb 24
10-K
2023 FY
Annual report
20 Feb 24
8-K
Arteris Announces Financial Results for the Fourth Quarter and Full Year 2023 and Estimated First Quarter and Full Year 2024 Guidance
20 Feb 24
10-Q
2023 Q3
Quarterly report
7 Nov 23
8-K
Arteris Announces Financial Results for the Third Quarter 2023 and Fourth Quarter and Full Year 2023 Guidance
7 Nov 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
8-K
Arteris Announces Financial Results for the Second Quarter 2023 and Estimated Third Quarter and Full Year 2023 Guidance
3 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
8 Jun 23
8-K
Termination of a Material Definitive Agreement
9 May 23
10-Q
2023 Q1
Quarterly report
4 May 23
8-K
Arteris Announces Financial Results for the First Quarter 2023 and Estimated Second Quarter and Full Year 2023 Guidance
4 May 23
ARS
2022 FY
Annual report to shareholders
24 Apr 23
DEFA14A
Additional proxy soliciting materials
24 Apr 23
DEF 14A
Definitive proxy
24 Apr 23
8-K
Changes in Registrant's Certifying Accountant
27 Mar 23
S-8
Registration of securities for employees
1 Mar 23
10-K
2022 FY
Annual report
28 Feb 23
8-K
Arteris Announces Financial Results for the Fourth Quarter and Full Year 2022 and Estimated First Quarter and Full Year 2023 Guidance
28 Feb 23
EFFECT
Notice of effectiveness
5 Dec 22
CORRESP
Correspondence with SEC
30 Nov 22
UPLOAD
Letter from SEC
15 Nov 22
S-8
Registration of securities for employees
8 Nov 22
S-3
Shelf registration
8 Nov 22
10-Q
2022 Q3
Quarterly report
8 Nov 22
8-K
Arteris Announces Financial Results for the Third Quarter 2022 and Estimated Fourth Quarter and Full Year 2022 Guidance
8 Nov 22
8-K
Arteris Announces Financial Results for the Second Quarter 2022 and Estimated Third Quarter and Full Year 2022 Guidance
9 Aug 22
10-Q
2022 Q2
Quarterly report
9 Aug 22
8-K
Submission of Matters to a Vote of Security Holders
17 Jun 22
10-Q
2022 Q1
Quarterly report
10 May 22
8-K
Arteris Announces Financial Results for the First Quarter 2022 and Estimated Second Quarter and Full Year 2022 Guidance
10 May 22
DEFA14A
Additional proxy soliciting materials
28 Apr 22
DEF 14A
Definitive proxy
28 Apr 22
8-K
Departure of Directors or Certain Officers
5 Apr 22
S-8
Registration of securities for employees
7 Mar 22
10-K
2021 FY
Annual report
7 Mar 22
Latest ownership filings
4
Nicholas B. Hawkins
14 May 24
4
Paul L Alpern
3 May 24
4
Nicholas B. Hawkins
15 Apr 24
4
Antonio J Viana
9 Apr 24
4
Nicholas B. Hawkins
4 Apr 24
4
Paul L Alpern
4 Apr 24
4
K CHARLES JANAC
4 Apr 24
4
Laurent R Moll
4 Apr 24
144
Notice of proposed sale of securities
4 Apr 24
144
Notice of proposed sale of securities
3 Apr 24
144
Notice of proposed sale of securities
3 Apr 24
4
Paul L Alpern
2 Apr 24
144
Notice of proposed sale of securities
2 Apr 24
4
Nicholas B. Hawkins
12 Mar 24
144
Notice of proposed sale of securities
11 Mar 24
4
Nicholas B. Hawkins
6 Mar 24
4
Laurent R Moll
6 Mar 24
4
K CHARLES JANAC
6 Mar 24
4
Paul L Alpern
5 Mar 24
144
Notice of proposed sale of securities
5 Mar 24
144
Notice of proposed sale of securities
5 Mar 24
144
Notice of proposed sale of securities
5 Mar 24
144
Notice of proposed sale of securities
4 Mar 24
4
K CHARLES JANAC
27 Feb 24
4
Nicholas B. Hawkins
13 Feb 24
4
Nicholas B. Hawkins
5 Feb 24
4
Paul L Alpern
5 Feb 24
4
Laurent R Moll
5 Feb 24
4
K CHARLES JANAC
5 Feb 24
144
Notice of proposed sale of securities
1 Feb 24
SC 13G/A
Bayview Legacy, LLC
24 Jan 24
SC 13G/A
Ventech Capital F
24 Jan 24
4
Nicholas B. Hawkins
23 Jan 24
4
Nicholas B. Hawkins
17 Jan 24
4
SAIYED ATIQ RAZA
11 Jan 24
4
Claudia F. Munce
8 Jan 24
4
SAIYED ATIQ RAZA
8 Jan 24
4
Nicholas B. Hawkins
8 Jan 24
4
K CHARLES JANAC
4 Jan 24
4
Laurent R Moll
4 Jan 24